RBC Capital Cuts Xylem (XYL) Price Target to $135
RBC Capital has reiterated its Outperform rating on Xylem with a revised price target of $135.0 as of October 14, 2026, a 30.21% upside from the current price.
Reviewed by automated data checks against the source data. How we make and check alerts
RBC Capital cut its price target on Xylem Inc. ($XYL) to $135 from $164 on October 14, 2026, and rates the stock "Outperform".
Since the rating, $XYL is up 1.3% to date (from the $102.74 close on Oct 14, 2026).
Key Points
- RBC Capital maintains an Outperform rating on Xylem Inc. (NYSE: XYL) and sets a new price target of $135.0, down from $164.0.
- RBC Capital's $135 price target implies 30.21% upside from Xylem Inc.'s ($XYL) current $103.68 share price.
- As of October 16, 2026, Xylem's shares were recently trading at $103.68, which is about 23.2% below RBC's new price target.
- Xylem reported trailing twelve-month revenue of $9.13 billion and has a dividend rate of $1.72 per share, with the next earnings date set for November 3, 2026.
Get $XYL trade alerts by text
We text you when insiders, Congress or big funds trade $XYL. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Xylem Inc. alert may contain errors. Disclosures
RBC Capital has reiterated its Outperform rating on Xylem Inc. (NYSE: XYL) and set a new price target of $135.0 on October 14, 2026. This is a decrease from the previous target of $164.0.
Xylem's shares were recently trading at $103.68 as of October 16, 2026, which places them about 23.2% below RBC’s new price target. The company's performance and future outlook continue to be important as it operates in the specialty industrial machinery sector, focusing on engineered products and solutions for water management.
Other Institutional Activity in Xylem
Several other institutional investors have adjusted their positions in Xylem recently. Blackrock Inc. reduced its holdings by 615,686 shares, ending with 25,037,896 shares valued at about $2.61 billion. Vanguard Capital Management LLC trimmed its position by 283,116 shares, resulting in 15,533,420 shares worth approximately $1.62 billion. Vanguard Portfolio Management LLC also decreased its stake by 151,973 shares, leaving it with 12,618,888 shares valued at roughly $1.31 billion. In contrast, State Street Corporation increased its holdings by 271,508 shares, totaling 11,444,669 shares worth about $1.19 billion.
Xylem Inc. Stock Down 3.6%
Xylem's stock is currently trading at $103.68, which is significantly below the new price target set by RBC. This could indicate a potential opportunity for investors, especially as the company prepares to report its earnings on November 3, 2026.
$XYL price target
Xylem Inc. daily closes and this analyst's $135 target. Not advice.
Recent Earnings
Xylem reported trailing twelve-month revenue of $9.13 billion, reflecting a year-over-year revenue growth of 1.5%. The company has an earnings per share (EPS) of $4.19 and a net profit margin of 11.2%. The next earnings report is scheduled for November 3, 2026.
Dividend
Xylem pays an annual dividend of $1.72 per share, resulting in a dividend yield of approximately 1.66%. The company's dividend payout ratio stands at 39.5%, indicating a balanced approach to returning value to shareholders while reinvesting in growth.
Insider Buying and Selling at Xylem Inc.
Recent insider transactions show that Jerome A. Peribere, a Director, bought 1,210 shares at an average price of $116.61 on May 4, 2026, totaling approximately $141,098. On the other hand, Victoria D. Harker, another Director, sold 1,700 shares at an average price of $148.14 on November 4, 2025, for around $251,838. Geri-Michelle Mcshane, an Officer, sold 4,269 shares at an average price of $117.46 on May 7, 2026, valued at about $501,437.
Analysts Set New Price Targets
On October 5, 2026, UBS maintained a Neutral rating on Xylem with a price target of $112.0, down from $138.0. Citigroup kept its Buy rating with a target of $148.0, lowered from $172.0 on October 12, 2026. Barclays also maintained an Overweight rating with a new target of $139.0, down from $159.0 on October 13, 2026. RBC Capital's recent reiteration of its Outperform rating with a target of $135.0 reflects its confidence in Xylem’s long-term prospects despite the recent adjustments.
About Xylem
Xylem Inc., based in Washington, DC, designs and manufactures products and solutions for water management. It serves utility, industrial, and commercial sectors worldwide. With a workforce of about 22,000 employees, Xylem is a key player in the specialty industrial machinery industry, focusing on sustainable water solutions.
Bottom Line
Investors should keep an eye on Xylem's upcoming earnings report on November 3, 2026, for further insights into its performance. The recent rating changes by analysts, alongside the company's strategic focus on water management, will be crucial to watch as market conditions evolve.
Source: RBC Capital's rating change on $XYL (Oct 14, 2026). Written by software, not financial advice. How we make alerts